107 related articles for article (PubMed ID: 36750540)
61. Influence of TLR4 and TLR9 polymorphisms and haplotypes on multiple hrHPV infections and HPV16 copy number in cervical cancer and cervicitis.
Pandey N; Chauhan A; Raithatha N; Patel P; Khandelwal R; Desai A; Choxi Y; Kapadia R; Jain N
Microb Pathog; 2021 Oct; 159():105149. PubMed ID: 34416273
[TBL] [Abstract][Full Text] [Related]
62. Expression pattern and subcellular localization of human papillomavirus minor capsid protein L2.
Lin Z; Yemelyanova AV; Gambhira R; Jagu S; Meyers C; Kirnbauer R; Ronnett BM; Gravitt PE; Roden RB
Am J Pathol; 2009 Jan; 174(1):136-43. PubMed ID: 19095951
[TBL] [Abstract][Full Text] [Related]
63. [Detection of HPV16 E6 gene in cervical tissues by quantitative polymerase chain reaction].
Luo B; Wang Y; Wang Y; Yu Q; Dai SZ; Wang B
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):248-50. PubMed ID: 11986698
[TBL] [Abstract][Full Text] [Related]
64. Methylation of twelve CpGs in human papillomavirus type 16 (HPV16) as an informative biomarker for the triage of women positive for HPV16 infection.
Brandsma JL; Harigopal M; Kiviat NB; Sun Y; Deng Y; Zelterman D; Lizardi PM; Shabanova VS; Levi A; Yaping T; Hu X; Feng Q
Cancer Prev Res (Phila); 2014 May; 7(5):526-33. PubMed ID: 24556390
[TBL] [Abstract][Full Text] [Related]
65. HPV16 CpG methyl-haplotypes are associated with cervix precancer and cancer in the Guanacaste natural history study.
Frimer M; Sun C; McAndrew T; Smith B; Harari A; Chen Z; Mirabello L; Wentzensen N; Goldberg GL; Rodriguez AC; Schiffman M; Burk RD
Gynecol Oncol; 2015 Jul; 138(1):94-100. PubMed ID: 26001326
[TBL] [Abstract][Full Text] [Related]
66. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
67. [Analysis of the relative distribution and gene variation of HPV16 transforming gene at different stages of cervical lesions].
Zhang F; Ding XH; Cai HB; Wang H; Chen CC; Zhang S
Zhonghua Zhong Liu Za Zhi; 2010 Feb; 32(2):107-10. PubMed ID: 20403240
[TBL] [Abstract][Full Text] [Related]
68. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique.
Peitsaro P; Johansson B; Syrjänen S
J Clin Microbiol; 2002 Mar; 40(3):886-91. PubMed ID: 11880410
[TBL] [Abstract][Full Text] [Related]
69. The application of BMRT-HPV viral load to secondary screening strategies for cervical cancer.
Duan L; Du H; Wang C; Huang X; Qu X; Shi B; Liu Y; Zhang W; Duan X; Wei L; Belinson JL; Wu R
PLoS One; 2020; 15(5):e0232117. PubMed ID: 32357165
[TBL] [Abstract][Full Text] [Related]
70. Oncolytic Adenovirus H101 Synergizes with Radiation in Cervical Cancer Cells.
Duan Y; Bai H; Li X; Wang D; Wang Y; Cao M; Zhang N; Chen H; Wang Y
Curr Cancer Drug Targets; 2021; 21(7):619-630. PubMed ID: 33687882
[TBL] [Abstract][Full Text] [Related]
71. Impact of modulation of telomerase and cancer stem-cell marker OCT4 axis in cervical cancer pathogenesis with underlying HPV16 infection.
Tiwari D; Ray Das C; Sultana R; Kakoti S; Aasif Khan M; Dongre A; Husain SA; Bose PD; Bose S
J Cell Biochem; 2020 Apr; 121(4):2782-2791. PubMed ID: 31692038
[TBL] [Abstract][Full Text] [Related]
72. Evaluation of human-papillomavirus screening for cervical cancer in China's rural population.
Li L; Zheng Z; Li L
PeerJ; 2019; 7():e8152. PubMed ID: 31875147
[TBL] [Abstract][Full Text] [Related]
73. Associations of high-risk HPV types and viral load with cervical cancer in China.
Wu Y; Chen Y; Li L; Yu G; Zhang Y; He Y
J Clin Virol; 2006 Mar; 35(3):264-9. PubMed ID: 16183329
[TBL] [Abstract][Full Text] [Related]
74. miR-9, miR-21, miR-27b, and miR-34a Expression in HPV16/58/52-Infected Cervical Cancer.
Liu M; Wang W; Chen H; Lu Y; Yuan D; Deng Y; Ran D
Biomed Res Int; 2020; 2020():2474235. PubMed ID: 33015156
[TBL] [Abstract][Full Text] [Related]
75. HPV16/18 prevalence in cervical lesions/cancers and p53 genotypes in cervical cancer patients from India.
Saranath D; Khan Z; Tandle AT; Dedhia P; Sharma B; Contractor R; Shrivastava S; Dinshaw K
Gynecol Oncol; 2002 Aug; 86(2):157-62. PubMed ID: 12144822
[TBL] [Abstract][Full Text] [Related]
76. Comparison of the sensitivity and specificity of real-time PCR and in situ hybridization in HPV16 and 18 detection in archival cervical cancer specimens.
Biesaga B; Szostek S; Klimek M; Jakubowicz J; Wysocka J
Folia Histochem Cytobiol; 2012 Jul; 50(2):239-47. PubMed ID: 22763968
[TBL] [Abstract][Full Text] [Related]
77. Neutralizing antibodies against oncogenic human papillomavirus as a possible determinant of the fate of low-grade cervical intraepithelial neoplasia.
Kawana K; Yasugi T; Kanda T; Kawana Y; Hirai Y; Yoshikawa H; Taketani Y
Biochem Biophys Res Commun; 2002 Aug; 296(1):102-5. PubMed ID: 12147233
[TBL] [Abstract][Full Text] [Related]
78. HPV16 E6 oncogene variants in women with cervical intraepithelial neoplasia.
Luxton J; Mant C; Greenwood B; Derias N; Nath R; Shepherd P; Cason J
J Med Virol; 2000 Mar; 60(3):337-41. PubMed ID: 10630967
[TBL] [Abstract][Full Text] [Related]
79. [High-risk HPV genotyping PCR testing as a means of cervical cancer and precancerous lesions early screening].
Ma L; Cong X; Bian M; Shi M; Wang X; Liu J; Liu H
Zhonghua Fu Chan Ke Za Zhi; 2015 Apr; 50(4):246-52. PubMed ID: 26080934
[TBL] [Abstract][Full Text] [Related]
80. [Expression, purification, and serum antibody detection of HPV16 E6 in cervical cancer patients].
Gao YE; Guo JZ; Zhang J; Song TB; Yan XJ
Ai Zheng; 2006 Nov; 25(11):1374-9. PubMed ID: 17094904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
